ATE397921T1 - Neue verwendung von frk-tyrosinekinase inhibitoren - Google Patents
Neue verwendung von frk-tyrosinekinase inhibitorenInfo
- Publication number
- ATE397921T1 ATE397921T1 AT02720710T AT02720710T ATE397921T1 AT E397921 T1 ATE397921 T1 AT E397921T1 AT 02720710 T AT02720710 T AT 02720710T AT 02720710 T AT02720710 T AT 02720710T AT E397921 T1 ATE397921 T1 AT E397921T1
- Authority
- AT
- Austria
- Prior art keywords
- frk
- tyrosine kinase
- relates
- inhibitor
- type
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0101230A SE0101230L (sv) | 2001-04-06 | 2001-04-06 | Ny användning av en tyrosinkinasinhibitor |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE397921T1 true ATE397921T1 (de) | 2008-07-15 |
Family
ID=20283697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02720710T ATE397921T1 (de) | 2001-04-06 | 2002-04-05 | Neue verwendung von frk-tyrosinekinase inhibitoren |
Country Status (7)
Country | Link |
---|---|
US (1) | US20040171563A1 (de) |
EP (1) | EP1372621B1 (de) |
AT (1) | ATE397921T1 (de) |
DE (1) | DE60227058D1 (de) |
DK (1) | DK1372621T3 (de) |
SE (1) | SE0101230L (de) |
WO (1) | WO2002080894A1 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060094682A1 (en) * | 2004-10-29 | 2006-05-04 | Odyssey Thera, Inc. | Kinase inhibitors for the treatment of diabetes and obesity |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6177401B1 (en) * | 1992-11-13 | 2001-01-23 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften | Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis |
US5880141A (en) * | 1995-06-07 | 1999-03-09 | Sugen, Inc. | Benzylidene-Z-indoline compounds for the treatment of disease |
GB9718913D0 (en) * | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Substituted oxindole derivatives |
GB9721437D0 (en) * | 1997-10-10 | 1997-12-10 | Glaxo Group Ltd | Heteroaromatic compounds and their use in medicine |
WO2003022815A1 (en) * | 2001-09-10 | 2003-03-20 | Sugen, Inc. | 3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene)-2-indolinone derivatives as kinase inhibitors |
-
2001
- 2001-04-06 SE SE0101230A patent/SE0101230L/ not_active Application Discontinuation
-
2002
- 2002-04-05 DK DK02720710T patent/DK1372621T3/da active
- 2002-04-05 DE DE60227058T patent/DE60227058D1/de not_active Expired - Fee Related
- 2002-04-05 US US10/473,765 patent/US20040171563A1/en not_active Abandoned
- 2002-04-05 AT AT02720710T patent/ATE397921T1/de not_active IP Right Cessation
- 2002-04-05 EP EP02720710A patent/EP1372621B1/de not_active Expired - Lifetime
- 2002-04-05 WO PCT/SE2002/000682 patent/WO2002080894A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
SE0101230D0 (sv) | 2001-04-06 |
EP1372621A1 (de) | 2004-01-02 |
SE0101230L (sv) | 2002-10-07 |
WO2002080894A1 (en) | 2002-10-17 |
DK1372621T3 (da) | 2008-10-20 |
EP1372621B1 (de) | 2008-06-11 |
DE60227058D1 (de) | 2008-07-24 |
US20040171563A1 (en) | 2004-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20051103L (no) | Indol-3-karboksamider som Glukokinase-(GK)-Aktivatorer | |
IS7753A (is) | Beta-amínó heterósýklískir dípeptidýl peptíðasa hindrar til meðhöndlunar á, eða til að fyrirbyggja,sykursýki | |
NO20083026L (no) | Terapeutisk middel for diabetes | |
HUP0402403A2 (hu) | Cukorbetegség-ellenes hatású dipeptilpeptidáz IV (DP-IV) inhibitorok ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
MY127961A (en) | Beta-amino heterocyclic dipetidyl peptidase inhibitors for the treament or prevention of diabetes | |
DE60310991D1 (de) | Phenylalaninderivate als hemmer der dipeptidyl peptidase zur behandlung oder prävention von diabetes | |
YU34404A (sh) | N-supstituisani derivati pirolidina kao inhibitori dipeptidil-peptidaze iv | |
MX2010001784A (es) | Activadores novedosos de la glucocinasa. | |
EP1490335A4 (de) | Heterocyclische beta-aminoverbindungen als inhibitoren der dipeptidylpeptidase zur behandlung bzw. prävention von diabetes | |
UA88257C2 (ru) | ПРИМЕНЕНИЕ ИНГИБИТОРА ПРОТЕИНКИНАЗЫ С-α ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ПОЧЕК, КОТОРЫЕ ПРИВОДЯТ К ПРОТЕИНУРИИ, И ДИАБЕТИЧЕСКИМ РЕТИНОПАТИИ, НЕВРОПАТИИ ИЛИ НЕФРОПАТИИ | |
EP1554280A4 (de) | Antidiabetische heterocyclische beta-aminoverbindungen als inhibitoren von dipeptidylpeptidase | |
DE60330485D1 (de) | Zur behandlung von diabetes | |
ATE537152T1 (de) | Verbindungen, ihre pharmazeutischen zusammensetzungen und ihre verwendung in der behandlung von stoffwechselstörungen | |
NO20091596L (no) | Benzoylamino-heterocykliske forbindelser som Glucokinase-(GLK)-activatorer | |
DE60110054D1 (en) | Cardioprotektive phosphonate | |
WO2006012395A3 (en) | Peptidase inhibitors | |
DK1143955T3 (da) | En kombination af FBPase-inhibitorer og insulinsensibiliseringsmidler til behandling af diabetes | |
ATE397921T1 (de) | Neue verwendung von frk-tyrosinekinase inhibitoren | |
ATE397924T1 (de) | Satraplatin zur behandlung von resistenten oder refrkatären tumoren | |
SE0200198D0 (sv) | New use | |
SI1399156T1 (sl) | Derivati alkiliden pirazolidindiona in njihova uporaba pri zdravljenju diabetesa in debelosti | |
DE60312656D1 (de) | Arzneimittel zur behandlung von störungen des zirkadianen rhythmus | |
DK1397124T3 (da) | Anvendelse af diabetesmidler til fremstilling af et lægemiddel med helende virkning | |
WO2002023784A3 (en) | Cysteine protease inhibitors | |
MY138965A (en) | Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |